[Familial syndrome with parkinsonian tremor and anosmia and its therapy with L-dopa associated with a decarboxylase inhibitor].
作者信息
Constantinidis J, de Ajuriaguerra J
出版信息
Therapeutique. 1970 Mar;46(3):263-9.
PMID:5422192
Abstract
摘要
相似文献
1
2
[L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
Dtsch Med Wochenschr. 1972 Aug 25;97(34):1246-8. doi: 10.1055/s-0028-1107539.
3
[Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects].[帕金森综合征、抑郁或躁狂综合征患者通过灌注给予左旋多巴（联合或不联合脱羧酶抑制剂）时脑和外周左旋多巴摄取情况。药理作用]
Encephale. 1972 Mar-Apr;61(2):127-48.
4
5
[Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].使用左旋多巴联合脱羧酶抑制剂治疗帕金森病
Fortschr Neurol Psychiatr Grenzgeb. 1972 Oct;40(10):564-8.
6
7
[Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].[左旋多巴与脱羧酶抑制剂（Ro 4-4602）治疗帕金森综合征。71例患者的病程]
Schweiz Med Wochenschr. 1972 Jan 22;102(3):88-94.
8
9
[Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa?].
Presse Med (1893). 1971 Jan 16;79(3):91-2.
10
[Therapy of parkinsonism using a combination of L-dopa and decarboxylase inhibitor].左旋多巴与脱羧酶抑制剂联合治疗帕金森病
Med Welt. 1973 Apr 27;24(17):705-7.
引用本文的文献
1
α-Synuclein Pathology and Reduced Neurogenesis in the Olfactory System Affect Olfaction in a Mouse Model of Parkinson's Disease.α-突触核蛋白病理学和嗅觉系统中的神经发生减少会影响帕金森病小鼠模型的嗅觉。
J Neurosci. 2023 Feb 8;43(6):1051-1071. doi: 10.1523/JNEUROSCI.1526-22.2022. Epub 2023 Jan 3.
2
The prion hypothesis of Parkinson's disease.帕金森病的朊病毒假说。
Curr Neurol Neurosci Rep. 2015 May;15(5):28. doi: 10.1007/s11910-015-0549-x.
3
[Evaluating function and disorders of smell].[嗅觉功能与障碍评估]
Arch Otorhinolaryngol. 1975;210(1):67-164. doi: 10.1007/BF00453708.
Zotero 插件